Artrya Ltd
ASX:AYA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tietoevry Oyj
OMXH:TIETO
|
FI |
Artrya Ltd
PP&E Net
Artrya Ltd
PP&E Net Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Artrya Ltd
ASX:AYA
|
PP&E Net
AU$1.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
123%
|
CAGR 10-Years
N/A
|
|
|
4DMedical Ltd
ASX:4DX
|
PP&E Net
AU$6.6m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
CogState Ltd
ASX:CGS
|
PP&E Net
$960.2k
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-4%
|
|
|
Pro Medicus Ltd
ASX:PME
|
PP&E Net
AU$3.1m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
24%
|
|
|
Alcidion Group Ltd
ASX:ALC
|
PP&E Net
AU$1.1m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
16%
|
CAGR 10-Years
60%
|
|
|
B
|
BlinkLab Ltd
ASX:BB1
|
PP&E Net
AU$147.5k
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Artrya Ltd
Glance View
Artrya Ltd. develops the Salix suite of products to address coronary artery disease (CAD). The company is headquartered in Perth, Western Australia. The company went IPO on 2021-11-26. The firm is focused on operating diagnostic imaging center. The company is primarily engaged in providing powered image-analysis software for coronary artery disease. Its non-invasive solution, Salix uses artificial intelligence (AI) to produce a 3D image and report that provides an accurate detection of coronary artery disease, including the presence of vulnerable plaque. Salix offers precision medicine for cardiac care. The company enables clinicians to triage patients and identify individuals at high risk of heart attack. The firm's cardiac-health report provides diagnostic support to radiologists and cardiologists.
See Also
What is Artrya Ltd's PP&E Net?
PP&E Net
1.5m
AUD
Based on the financial report for Jun 30, 2025, Artrya Ltd's PP&E Net amounts to 1.5m AUD.
What is Artrya Ltd's PP&E Net growth rate?
PP&E Net CAGR 5Y
123%
Over the last year, the PP&E Net growth was -17%. The average annual PP&E Net growth rates for Artrya Ltd have been -15% over the past three years , 123% over the past five years .
